Tag: Ziylo
Novo Nordisk acquires glucose binding molecules developer Ziylo
Novo Nordisk acquisition of Ziylo : Danish pharma company Novo Nordisk has acquired Ziylo, a University of Bristol spin-out biotechnology company, in a deal that ... Read More